|
Volumn 424, Issue 1, 2001, Pages 53-58
|
The effect of adrenergic compounds on neurogenic dural vasodilatation
|
Author keywords
Adrenergic compound; Headache; Migraine; Trigeminovascular
|
Indexed keywords
ADRENERGIC RECEPTOR STIMULATING AGENT;
BRIMONIDINE;
CORYNANTHINE;
PENTOBARBITAL;
PHENYLEPHRINE;
PROPRANOLOL;
YOHIMBINE;
ADRENERGIC SYSTEM;
ADRENERGIC TRANSMISSION;
ANALYTIC METHOD;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTERY DIAMETER;
ARTICLE;
CONTROLLED STUDY;
DEPOLARIZATION;
DRUG EFFECT;
DRUG MECHANISM;
DURA MATER;
ELECTROSTIMULATION;
EXTRAVASATION;
MALE;
MIGRAINE;
NERVE FIBER;
NONHUMAN;
PHARMACOLOGICAL BLOCKING;
PRIORITY JOURNAL;
RAT;
TRIGEMINAL NERVE;
TRIGEMINUS ARTERY;
VASODILATATION;
ADRENERGIC AGENTS;
ADRENERGIC ALPHA-AGONISTS;
ADRENERGIC ALPHA-ANTAGONISTS;
ADRENERGIC BETA-ANTAGONISTS;
ANIMALS;
BLOOD PRESSURE;
BLOOD VESSELS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DURA MATER;
ELECTRIC STIMULATION;
INJECTIONS, INTRAVENOUS;
MALE;
PHENYLEPHRINE;
PROPRANOLOL;
QUINOXALINES;
RATS;
RATS, SPRAGUE-DAWLEY;
RECEPTORS, ADRENERGIC, ALPHA-1;
RECEPTORS, ADRENERGIC, ALPHA-2;
TIME FACTORS;
VASODILATION;
YOHIMBINE;
|
EID: 0035854561
PISSN: 00142999
EISSN: None
Source Type: Journal
DOI: 10.1016/S0014-2999(01)01111-6 Document Type: Article |
Times cited : (33)
|
References (36)
|